drugset / Trial / NCT06993662

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

NCT06993662

Phase 1 Active not recruiting 107 enrolled Rakitzi, Stavroula
Non-randomizedParallel-groupSingle-blindTreatment

Summary

The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.

Timeline

Start
2025-06-02
Primary completion
2027-12-20
Completion
2027-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromazepam Small molecule
Subject Clozapine Other / unclassified
Subject Lithium Unknown
Subject Tavor Unknown
Subject Valproic Acid Small molecule
Subject clonotril Unknown